| Stage | BAH | % of rev | EXPO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.8B | 100.00% | $172M | 100.00% | BAH ×16.19 |
| Gross profit | $1.4B | 52.02% | $71M | 41.40% | BAH +10.6pp |
| Operating income | $245M | 8.82% | $28M | 16.33% | EXPO +7.5pp |
| Pre-tax income | $199M | 7.16% | $41M | 23.75% | EXPO +16.6pp |
| Net income | $181M | 6.52% | $29M | 17.13% | EXPO +10.6pp |
| Stage | BAH | EXPO | Gap · A − B |
|---|---|---|---|
| Revenue | $2.8B100.00% | $172M100.00% | BAH ×16.19 |
| Gross profit | 52.02%$1.4B | 41.40%$71M | BAH +10.6pp |
| Operating income | 8.82%$245M | 16.33%$28M | EXPO +7.5pp |
| Pre-tax income | 7.16%$199M | 23.75%$41M | EXPO +16.6pp |
| Net income |
| 6.52%$181M |
| 17.13%$29M |
| EXPO +10.6pp |
No shared counterparties.